You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博拓生物(688767.SH):存在歐洲、澳洲等新冠產品檢測市場競爭激烈等風險
格隆匯 01-12 21:17

格隆匯1月12日丨博拓生物(688767.SH)公佈股票交易異常波動公吿,公司股票於2022年1月10日、1月11日、1月12日連續三個交易日內日收盤價格漲幅偏離值累計超過30%。根據有關規定,屬於股票交易異常波動情形。

經公司自查並向控股股東及實際控制人核實,截至公吿披露日,不存在應披露而未披露的重大信息。

二級市場交易風險:公司特別提醒廣大投資者,公司流通股數量為2,221.0796萬股,佔發行後總股數的20.82%,上市流通盤小,存在被炒作的風險。公司提醒廣大投資者注意投資風險,避免跟風炒作,理性決策,審慎投資。

歐洲、澳洲等新冠產品檢測市場競爭激烈風險:公司的新型冠狀病毒抗原自測試劑產品在歐洲和澳洲市場存在多家同類產品或其他檢測類產品,公司產品將面臨激烈的市場競爭風險。

業績增長不確定風險:受境外疫情發展及疫情防控政策、市場競爭情況、國際疫情對技術產品的路徑選擇、公司產品競爭力和渠道能力、客户認可程度等多種因素影響,上述新冠產品的銷售額及利潤貢獻具有較大的不確定性。

其他導致公司經營業績的不可確定性的風險:受新冠疫苗接種計劃及新冠特效藥推行,公司產品產能擴張受限等影響,公司的經營業績也存在一定的不可預測性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account